"Linh has a proven track record of building the financial and operational ... He previously held the role of chief operating officer at Ambry Genetics, where he led organization-wide change ...

Hereditary testing, which is how we’re going to refer to the legacy Ambry Genetics business ... I think when we began discussing this idea of building a foundation model, it made sense for ...

The company successfully closed the Ambry Genetics acquisition on February ... driving utility in new crypto categories, and building foundations for the next decade of growth.

Ambry Genetics was the first commercial laboratory to begin offering clinical diagnostic exome sequencing testing in 2011 3, which may bring new hope to thousands of patients and families searching ...

The acquisitions of Ambry Genetics and Deep 6 AI are expected to have contributed to Tempus AI's strategic expansion during the first quarter of 2025. The acquisition of Ambry Genetics ...

The company has also outperformed other players in the health infotech field, like 10x Genomics TXG and SOPHiA GENETICS SOPH. While TXG declined 39.2%, SOPH gained 8.1% during the said period.

Tempus AI reports first-quarter revenue of $255.74 million, beating estimates of $248.13 million. The company reports a first-quarter adjusted loss of 24 cents per share, beating analyst ...